Open AccessConcurrent β-blocker Use is Associated With Improved Outcome in Esophageal Cancer Patients Who Undergo Chemoradiation
Author(s) -
Mark Farrugia,
Sung Jun,
David Mattson,
L. Flaherty,
Elizabeth A. Repasky,
Anurag Singh
Publication year - 2020
Publication title -
american journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.896
H-Index - 78
eISSN - 1537-453X
pISSN - 0277-3732
DOI - 10.1097/coc.0000000000000768
Subject(s) - medicine , esophageal cancer , interquartile range , hazard ratio , cancer , cohort , oncology , retrospective cohort study , proportional hazards model , chemoradiotherapy , aspirin , surgery , confidence interval
β-blocker use has been associated with improved outcomes in a number of different malignancies; however, the impact of β-blockade in esophageal cancer is not been well characterized. We compared the outcomes of esophageal cancer patients based on β-blocker usage.